The concentrations of Bcl-2 in LE-PBMCs from IBD patients were significantly lower as compared to healthy volunteers (16.8 ng/ml (14.5-19.5) vs. 35.1 ng/ml (26.3-46.7), p<0.001). This evidence concerns the gene BCL2 and inflammatory bowel disease.